Table 1. Test of the assumption of normality using the Shapiro-Wilks test at α=0.001 level of significance.
NSS: normal saline solution; Sig.: level of significance
If p>α, the sample data have been drawn from a normally distributed population.
Phase | Treatment | Shapiro-Wilk | ||
Statistic | df | Sig. | ||
In vitro clot lysis at 90 minutes | Venom 1:0 | 0.987 | 6 | 0.981 |
Venom 3:4 | 0.966 | 6 | 0.866 | |
Venom 1:2 | 0.861 | 6 | 0.193 | |
Venom 1:3 | 0.901 | 6 | 0.377 | |
NSS (-) | 0.883 | 6 | 0.284 | |
Streptokinase (+) | 0.834 | 6 | 0.116 | |
In vitro clot lysis at 120 minutes | Venom 1:0 | 0.946 | 6 | 0.711 |
Venom 3:4 | 0.817 | 6 | 0.084 | |
Venom 1:2 | 0.885 | 6 | 0.293 | |
Venom 1:3 | 0.835 | 6 | 0.117 | |
NSS (-) | 0.917 | 6 | 0.485 | |
Streptokinase (+) | 0.900 | 6 | 0.373 | |
In vivo | Venom 1:1 | 0.964 | 3 | 0.637 |
Venom 1:16 | 0.964 | 3 | 0.637 | |
Venom 1:4 | 0.964 | 3 | 0.637 | |
Venom 1:64 | 1.000 | 3 | 1.000 | |
NSS (-) | 0.893 | 3 | 0.363 |